vimarsana.com
Home
Live Updates
Exai Bio and Quantum Leap Healthcare Collaborative Announce
Exai Bio and Quantum Leap Healthcare Collaborative Announce
Exai Bio and Quantum Leap Healthcare Collaborative Announce Expanded Participation in I-SPY 2 Trial to Advance Exai's Novel RNA-based Liquid Biopsy Platform in Breast Cancer
/PRNewswire/ -- Exai Bio today announced a collaboration agreement with Quantum Leap Healthcare Collaborative™ (QLHC) to broaden the use of Exai's novel,...
Related Keywords
San Antonio ,
Texas ,
United States ,
California ,
San Francisco ,
Laura Esserman ,
Pat Arensdorf ,
Prnewswire Exai Bio ,
Biomarker Working Group ,
Drug Administration ,
University Of California ,
Quantum Leap Healthcare Collaborative ,
Antonio Breast Cancer Symposium ,
Chief Executive Officer ,
Serial Studies ,
Predict Your Therapeutic Response ,
Imaging And ,
Molecular Analysis ,
Leap Healthcare Collaborative ,
Silicon Valley ,